Tulip BioMed, Inc.: Tulip BioMed CEO Chosen as One of “Reader Favorites” in Inc. Magazine’s Entrepreneur of the Year
Tulip BioMed CEO Chosen as One of “Reader Favorites” in Inc. Magazine’s Entrepreneur of the YearPublic Shows Interest in Safer Disposable Instruments for Plastic Surgery SAN DIEGO, CA — (MARKET WIRE) — December 14, 2006 — Founder and CEO Marc Pilkington of TulipBioMed™,
Inc. (PINKSHEETS: TPBD), a developer of medical devices andpatented technologies for thelivingtissue markets, including plastic, cosmetic, and orthopedic surgeries,has been identified by Inc. Magazine as one of the top 13 “ReaderFavorites” in its Entrepreneur of the Year contest announced this week.
Pilkington was selected for starting a company that is focused on providingsafer instruments for liposuction, fat transfer and other micro-surgeries.The minimally invasive disposable instruments developed by Tulip BioMed aredesigned to solve cross-contamination issues by eliminating reuse ofclosed-end cannulas used in these and other surgical procedures. Alubricious coating, which covers both the inside and outside of thecannula, is designed to not only decrease the trauma to the cells insidethe lumen, but also to increase the ease of manipulation for extraction andre-injection procedures, minimize bruising and shorten recovery periods.
Over several months prior to the “Entrepreneur of the Year” list arrival,the magazine invited business people and entrepreneurs to nominate othersor themselves as possible contenders. Approximately one hundred nominationswere received. Pilkington was nominated by one of Tulip BioMed’s vendors.The nominees were screened by the Inc. editors and those who qualified wereadded to the Inc. Website for readers to review and vote on.
Readers were given several weeks to review all nominations, assign anumerical rating on a scale of 1-10, and add comments. According to amagazine spokesperson, many hundreds of comments were received and morepeople voted than commented. At the end of the voting period, the top 13″Reader Favorites,” based on highest numerical ratings for how important orinteresting the nominations were, were announced on the site this week:http://www.inc.com/slideshow_INC/slideviewer.cgi?list=eoy20061208&dir=&config=&refresh=15&direction=forward&scale=0&cycle=on&slide=11&design=default&total=15
“It’s great to know that Inc.’s readers are concerned about safety in thesesurgical procedures. We believe we have a great product and I can see fromthe comments that others are starting to get it, too,” said Pilkington. “Iam honored to have been chosen as one of the Reader Favorites.”
About Tulip BioMed, Inc.
Tulip BioMed, Inc. (PINKSHEETS: TPBD) is a Nevada corporation withoperations based in San Diego, California. Founded in 2004, Tulip BioMed,Inc. is a medical device, biotechnology company that manufactures anddistributes patented technologies for the plastic and cosmetic surgery,biopsy, orthopedic surgery, stem cell therapy and other living tissuemarkets. Tulip BioMed, Inc. is the exclusive licensee of patented syringeconnection devices that use the worldwide recognized Tulip brand name.Tulip BioMed, Inc. manufactures, markets, and distributes medical devices,adapted with these and other patented technologies, to physicians, clinics,military, health organizations, hospitals and other distribution outlets.For more information go to: www.tulipbiomed.com. Products are available forsale at www.tulipdisposable.com.
Safe Harbor: This press release contains certain forward-lookinginformation about Tulip BioMed, Inc., which is intended to be covered bythe safe harbor for “forward-looking statements” provided by the PrivateSecurities Litigation Reform Act of 1995. Forward-looking statements arestatements that are not historical facts. Words such as “expect(s),”"feel(s),” “believe(s),” “will,” “may,” “anticipate(s),” and similarexpressions are intended to identify forward-looking statements. Thesestatements include, but are not limited to, financial projections andestimates and their underlying assumptions; statements regarding plans,objectives and expectations with respect to future operations, products andservices; and statements regarding future performance. Such statements aresubject to certain risks and uncertainties, many of which are difficult topredict and generally beyond the control of Tulip BioMed, Inc., that couldcause actual results to differ materially from those expressed in, orimplied or projected by, the forward-looking information and statements.These risks and uncertainties include: our lack of operating revenue andearnings history, our need for additional capital to pursue our businessstrategy. We are a non-reporting company and as such do not make periodicfilings with the Securities and Exchange Commission. We trade on the PinkSheets and there can be no assurances that a liquid market will develop inour securities. Readers are cautioned not to place undue reliance on theseforward-looking statements. Tulip BioMed, Inc. does not undertake anyobligation to republish revised forward-looking statements to reflectevents or circumstances after the date hereof or to reflect the occurrenceof unanticipated events.
Popularity: 1% [?]
